{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:34:56Z","timestamp":1790948096600,"version":"4.1.0"},"reference-count":21,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2012]]},"DOI":"10.1536\/ihj.53.331","type":"journal-article","created":{"date-parts":[[2012,10,3]],"date-time":"2012-10-03T23:22:02Z","timestamp":1349306522000},"page":"331-335","source":"Crossref","is-referenced-by-count":21,"title":["Azelnidipine Inhibits Msx2-Dependent Osteogenic Differentiation and Matrix Mineralization of Vascular Smooth Muscle Cells"],"prefix":"10.1536","volume":"53","author":[{"given":"Takehisa","family":"Shimizu","sequence":"first","affiliation":[{"name":"Department of Medicine and Biological Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Medicine and Biological Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Iso","sequence":"additional","affiliation":[{"name":"Department of Medicine and Biological Science"},{"name":"Education and Research Center, Gunma University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Kawai-Kowase","sequence":"additional","affiliation":[{"name":"Department of Medicine and Biological Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Kurabayashi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Biological Science"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Lehto S, Niskanen L, Suhonen M, R&ouml;nnemma T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996; 16: 978-83.","DOI":"10.1161\/01.ATV.16.8.978"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Davies MR, Hruska KA. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int 2001; 60: 472-9. (Review)","DOI":"10.1046\/j.1523-1755.2001.060002472.x"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00552.2003"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004; 15: 2959-64. (Review)","DOI":"10.1097\/01.ASN.0000145894.57533.C4"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Abedin M, Tintut Y, Demer LL. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004; 24: 1161-70. (Review)","DOI":"10.1161\/01.ATV.0000133194.94939.42"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Iyemere VP, Proudfoot D, Weissberg PL, Shanahan CM. Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med 2006; 260: 192-210. (Review)","DOI":"10.1111\/j.1365-2796.2006.01692.x"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90379-5"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200524140"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.109.187856"},{"key":"10","doi-asserted-by":"crossref","unstructured":"12. Pitt B, Byington RP, Furberg CD, <I>et al<\/I>. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation 2000; 102: 1503-10.","DOI":"10.1161\/01.CIR.102.13.1503"},{"key":"11","doi-asserted-by":"crossref","unstructured":"13. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-97.","DOI":"10.1001\/jama.288.23.2981"},{"key":"12","doi-asserted-by":"crossref","unstructured":"14. Mason RP, Marche P, Hintze TH. Novel vascular biology of third-generation L-type calcium channel antagonists: ancillary actions of amlodipine. Arterioscler Thromb Vasc Biol 2003; 23: 2155-63. (Review)","DOI":"10.1161\/01.ATV.0000097770.66965.2A"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000205497.90765.b0"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.SC0060064"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000185829.47163.32"},{"key":"16","doi-asserted-by":"crossref","unstructured":"19. Towler DA. Inorganic pyrophosphate: a paracrine regulator of vascular calcification and smooth muscle phenotype. Arterioscler Thromb Vasc Biol 2005; 25: 651-4. (Review)","DOI":"10.1161\/01.ATV.0000158943.79580.9d"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2008.12.041"},{"key":"18","doi-asserted-by":"crossref","unstructured":"21. Julius S, Kjeldsen SE, Weber M, <I>et al<\/I>. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004; 363: 2022-31.","DOI":"10.1016\/S0140-6736(04)16451-9"},{"key":"19","doi-asserted-by":"crossref","unstructured":"22. Yang H, Curinga G, Giachelli CM. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int 2004; 66: 2293-9.","DOI":"10.1111\/j.1523-1755.2004.66015.x"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-199805000-00019"},{"key":"21","doi-asserted-by":"crossref","unstructured":"24. Eickelberg O, Roth M, Mussmann R, <I>et al<\/I>. Calcium channel blockers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-kappaB in primary human vascular smooth muscle cells. Circulation 1999; 99: 2276-82.","DOI":"10.1161\/01.CIR.99.17.2276"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/53\/5\/53_331\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T07:14:30Z","timestamp":1618816470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/53\/5\/53_331\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.53.331","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}